Skip to main content
Elsevier
View Cart
openUserAccount

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

BooksJournals
151-160 of 531 results in All results

Peptidomics of Cancer-Derived Enzyme Products

  • 1st Edition
  • Volume 42
  • October 18, 2017
  • Tony Y. Hu + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 1 2 6 3 8 - 7
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 2 6 3 9 - 4
Peptidomics of Cancer-Derived Enzyme Products, Volume 42, the latest in The Enzymes series, is ideal for researchers in biochemistry, molecular and cell biology, pharmacology, and cancer, with this volume featuring high-caliber, thematic articles on the topic of peptidomics of cancer-derived enzyme products. Specific chapters cover Circulating peptidome and tumor-resident proteolysis, Colon tumor secretopeptidome, Chemoenzymatic method for glycomics, Human plasma peptidome for pancreatic cancer, Lipoproteomics and quantitative proteomics, Salivaomics: Protein markers/extracellular RNA/DNA in saliva, and Enzyme-responsive vectors for cancer therapy.

Medicinal Plants for Holistic Health and Well-Being

  • 1st Edition
  • September 27, 2017
  • Namrita Lall
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 1 2 4 7 5 - 8
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 2 4 7 6 - 5
Medicinal Plants for Holistic Health and Well-Being discusses, in depth, the use of South African plants to treat a variety of ailments, including tuberculosis, cancer, periodontal diseases, acne, postmacular hypomelanosis, and more. Plants were selected on the basis of their traditional use, and the book details the scientific evidence that supports their pharmacological and therapeutic potential to safely and effectively treat each disease. Thus, this book is a valuable resource for all researchers, students and professors involved in advancing global medicinal plant research. Many plants found in South Africa are also found in other parts of the world. Each chapter highlights plants from other worldwide locations so that scientists can study which plants belong to the same family, and how similar qualities can be used to treat a specific disease.

Cannabinoid Pharmacology

  • 1st Edition
  • Volume 80
  • August 18, 2017
  • David Kendall + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 1 1 2 3 2 - 8
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 1 2 3 3 - 5
Cannabinoid Pharmacology, Volume 80 is a new volume in the Advances in Pharmacology that presents reviews of recent breakthroughs. This volume aims to present current knowledge of the endogenous cannabinoid system, and looks at molecular, cellular, tissue and organismal effects of endogenous and exogenous cannabinoids. Topics of note in this new volume include Endocannabinoids and their congeners, Endocannabinoid turnover, Plant cannabinoids, Synthetic cannabinoids and ‘legal highs’, CB1 and CB2 cannabinoid receptors, Novel signaling modalities, Novel cannabinoid receptors, and Ion channel regulation by cannabinoids. There is a broad coverage of the essential elements associated with the cannabinoid system. The Editors have sought to include authors who represent authoritative voices on these themes, but have not previously worked together to allow a fresh approach to the individual aspects covered.

A Paradigm Shift to Prevent and Treat Alzheimer's Disease

  • 1st Edition
  • July 18, 2017
  • Howard Friel + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 1 2 2 5 9 - 4
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 2 2 7 9 - 2
A Paradigm Shift to Prevent and Treat Alzheimer’s Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols is the first book to systematically exhibit the powerful pleiotropic pharmacological effects on Alzheimer’s disease of plant-based compounds from ancient foods that humans have been consuming safely with substantial health benefits for thousands of years. These plant-based compounds include curcuminoids from turmeric, resveratrol from red wine and grape seed extract from other grape products, epigallocatechin-gallate (EGCG) from green tea, and oleocanthal and oleuropein from olive oil, in addition to a special extract, EGb 761, from the leaves of Ginkgo biloba, the oldest living species of tree on earth. This book also presents a new analytical framework that convincingly favors a multi-targeting ("pleiotropic") approach to the prevention and treatment of complex chronic diseases, in contrast to the mono-targeting of the pharmaceutical model. A Paradigm Shift to Prevent and Treat Alzheimer’s Disease is a unique and exciting resource for pharmaceutical scientists, pharmacologists, neurologists, general practitioners, research scientists in various medical and life sciences, healthcare professionals in clinical and executive positions, conventional medical schools, schools of naturopathic medicine, healthcare and medical journalists, executives in both national public healthcare systems and private insurers, and informed general readers.

From Artemisia annua L. to Artemisinins

  • 1st Edition
  • July 8, 2017
  • Youyou Tu
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 1 1 6 5 5 - 5
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 1 6 5 6 - 2
From Artemisia annua L. to Artemisinins: The Discovery and Development of Artemisinins and Antimalarial Agents is the first book that systematically introduces the origin and development of artemisinine and artemisinine-based drugs. It includes four distinct sections, including Artemisia annua L., Artemisinin, Dihydroartemisinin, and other artemisinin derivatives. Tu Youyou, the chief inventor of artemisinin, together with other members from the research team, have written a book that will be a valuable reference work for both researchers involved in the medical industry and scholars who are interested in undertaking innovative research.

Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy

  • 1st Edition
  • Volume 148
  • June 26, 2017
  • Raouf A Khalil
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 1 2 7 7 6 - 6
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 2 8 3 1 - 2
Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy, Volume, Volume 148, the latest volume in the Progress in Molecular Biology and Translational Science series covers a variety of timely topics, with chapters focusing on The Role of Matrix Metalloproteinases in Development, Repair, and Destruction of the Lungs, Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target, Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy, Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia, and Matrix Metalloproteinases, Neural Extracellular Matrix, and Central Nervous System Pathology. This volume is the second part of a thematic on matrix metalloproteinases and tissue remodeling in health and disease. It focuses on the role of MMPs in other systems, target tissues, and pathological disorders and the potential benefits of MMP inhibitors in various disorders.

A Comprehensive and Practical Guide to Clinical Trials

  • 1st Edition
  • June 7, 2017
  • Delva Shamley + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 0 4 7 2 9 - 3
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 4 7 3 0 - 9
A Comprehensive and Practical Guide to Clinical Trials provides an overview of the entire process of clinical research in one thorough and easy-to-read handbook that offers those involved in clinical research a clear understanding of how the components of a study are related. It focuses on the practical aspects of the preparation and execution of a clinical trial and offers tools and resources to help the entire team understand how their responsibilities tie together with the tasks and duties of other members. This allows for better planning and prioritization, and can lead to more effective and successful clinical trials. With practical examples, checklists and forms, this book is a useful guide for planning and conducting clinical trials from beginning to end.

Ion Channels Down Under

  • 1st Edition
  • Volume 79
  • May 18, 2017
  • Dominic Geraghty + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 1 0 4 1 3 - 2
  • eBook
    9 7 8 - 0 - 1 2 - 8 1 0 4 1 4 - 9
Ion Channels Down Under, Volume 79 provides up-to-date information on ion channel pharmacology, their pharmacological modulators, and their role in a diverse range of poorly treated medical conditions. This new volume covers specific topics relating to Receptors and the Diversity in their Structure and Pharmacology, Acid-Sensing Ion Channel Pharmacology, Past, Present and Future, Sodium Channels and Venom Peptide Pharmacology, the Role of Non-Neuronal TRPV4 Signaling in Inflammatory Processes, and Genetically Encoded Calcium Indicators as Probes to Assess the Role of Calcium Channels in Disease and for High-Throughput Drug Discovery. Contributors in this series include prominent scientists and highly-recognized experts with major accomplishments in the field of ion channel pharmacology. Topics covered include the role of ion channels in health and disease, ion channels as therapeutic targets and the molecular pharmacology of ion channels.

Adverse Events and Oncotargeted Kinase Inhibitors

  • 1st Edition
  • May 8, 2017
  • Giuseppe Tridente
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 0 9 4 0 0 - 6
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 9 4 4 5 - 7
Adverse Events and Oncotargeted Kinase Inhibitors gathers and evaluates data on adverse events associated with tyrosine kinase inhibitors (TKIs), a powerful anti-tumor drug class that has recently been introduced for human therapy. This book compiles a comprehensive safety profile of each TKI from experiences in official therapeutic indications, also exploring off-label exploratory investigations and postmarketing pharmaceutical surveillance databases. A brief history of each drug’s development and submission is provided, along with a more detailed analysis of the mechanism(s) of action involved in therapeutic activity or related to the insurgence of specific adverse events. Early chapters focus on general characteristics of TKIs, typology, and classification of adverse events, while the final chapters analyze TKIs as AE inducers and classes of AEs by system or organ involvement. This comprehensive resource compiles and critically reviews all of the relevant safety data for this class of drugs, with the goal of improving the understanding of pathogenesis and facilitating the prevention, monitoring, and management of these adverse events.

Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids

  • 1st Edition
  • April 4, 2017
  • Surendra Nimesh + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 0 8 - 1 0 0 5 5 7 - 6
  • eBook
    9 7 8 - 0 - 0 8 - 1 0 0 5 6 3 - 7
Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids addresses several issues related to safe and effective delivery of nucleic acids (NAs) using nanoparticles. A further emphasis would be laid on the mechanism of delivery of NAs, the barriers encountered and the strategies adapted to combat them. An exhaustive account of the advantages as well shortcomings of all the delivery vectors being employed in delivery of various NAs will be provided. On final note the regulatory aspects of nanoparticles mediated NA would be discussed, with focus on their clinical relevance. The design and development of nucleic acid-based therapeutics for the treatment of diseases arising from genetic abnormalities has made significant progress over the past few years. NAs have been widely explored for the treatment of cancer and infectious diseases or to block cell proliferation and thereby caused diseases. Advances in synthetic oligonucleotide chemistry resulted in synthesis of NAs that are relatively stable in in vivo environments. However, cellular targeting and intracellular delivery of NAs still remains a challenge. Further development of NA-based therapeutics depends on the progress of safe and effective carriers for systemic administration. Nanomedicine has facilitated availability of vectors with diminished cytotoxicity and enhanced efficacy which are rapidly emerging as systems of choice. These vectors protect NAs from enzymatic degradation by forming condensed complexes along with targeted tissue and cellular delivery. During the past few years, a myriad reports have appeared reporting delivery of NAs mediated by nanoparticles. This book will provide an overview of nanoparticles being employed in the in vitro and in vivo delivery of therapeutically relevant NAs like DNA, siRNA, LNA, PNA, etc.

Related subjects

Biochemical pharmacology

Cardiovascular pharmacology

Clinical pharmacology therapeutics

Clinical trials

Drug adverse reactions and interactions

Endocrine exocrine pharmacology

Ethnopharmacology

Gastrointestinal pharmacology

Immunopharmacology pharmacology

Molecular pharmacology

Neoplastic cancer pharmacology

Pharmacokinetics pharmacodynamics

Pharmacology general

Psychoneuropharmacology

Pulmonary pharmacology

Renal and electrolyte pharmacology